Novel 3-chlorooxazolidin-2-ones as antimicrobial agents
摘要:
Antimicrobial resistance against many known therapeutics is on the rise. We examined derivatives of 3-chlorooxazolidin-2-one 1a (X = H) as antibacterial and antifungal agents. The key findings were that the activity and apparent in vitro cytotoxicity could be controlled by the substitution of charged solubilizers at the 4- and 5-positions. These changes both significantly increase the antifungal potency and decrease cytotoxicity. Particularly effective were trialkylammonium groups which led to 400- to 600-fold increases in the antifungal therapeutic index when compared to their unsubstituted counterparts. (C) 2011 Elsevier Ltd. All rights reserved.
[EN] ANTIMICROBIAL POLYETHER AND POLYOL COMPOUNDS<br/>[FR] COMPOSÉS POLYÉTHER ET POLYOL ANTIMICROBIENS
申请人:NOVABAY PHARMACEUTICALS INC
公开号:WO2012054521A8
公开(公告)日:2012-08-30
ANTIMICROBIAL POLYETHER AND POLYOL COMPOUNDS
申请人:NovaBay Pharmaceuticals, Inc.
公开号:EP2629607A2
公开(公告)日:2013-08-28
Antimicrobial Polyether and Polyol Compounds
申请人:Jain Rakesh K.
公开号:US20120129793A1
公开(公告)日:2012-05-24
The present application describes compounds of Formula I and Formula IA and as disclosed herein, that are useful as anti-microbial agents, including as antibacterial, disinfectant, antifungal, germicidal or antiviral agents.
US9248117B2
申请人:——
公开号:US9248117B2
公开(公告)日:2016-02-02
Novel 3-chlorooxazolidin-2-ones as antimicrobial agents
作者:Timothy P. Shiau、Eric D. Turtle、Charles Francavilla、Nichole J. Alvarez、Meghan Zuck、Lisa Friedman、Donogh J.R. O’Mahony、Eddy Low、Mark B. Anderson、Ramin (Ron) Najafi、Rakesh K. Jain
DOI:10.1016/j.bmcl.2011.03.036
日期:2011.5
Antimicrobial resistance against many known therapeutics is on the rise. We examined derivatives of 3-chlorooxazolidin-2-one 1a (X = H) as antibacterial and antifungal agents. The key findings were that the activity and apparent in vitro cytotoxicity could be controlled by the substitution of charged solubilizers at the 4- and 5-positions. These changes both significantly increase the antifungal potency and decrease cytotoxicity. Particularly effective were trialkylammonium groups which led to 400- to 600-fold increases in the antifungal therapeutic index when compared to their unsubstituted counterparts. (C) 2011 Elsevier Ltd. All rights reserved.